Adupa P Rao
Keck Medicine of USC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Adupa P Rao as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:00 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT04840862 · Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/IvacaftorUniversity of Southern California · completed · Drug Drug Interaction · study director
- Ph4NCT04460586 · Pharmacokinetics of Omadacycline in Cystic FibrosisPaul Beringer · completed · Cystic Fibrosis · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:00 UTC. The ranking covers the 200 most relevant of 10 PubMed records, and a shared surname and initials can bring in a namesake. All 10 on PubMed
- Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis.Antimicrob Agents Chemother · 201742 citationsRCR 2.2
- GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis.J Cyst Fibros · 200932 citationsRCR 1.1
- Investigating feasibility of 2021 WHO protocol for cervical cancer screening in underscreened populations: PREvention and SCReening Innovation Project Toward Elimination of Cervical Cancer (PRESCRIP-TEC).BMC Public Health · 202222 citationsRCR 2.2
- Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine.J Clin Pharmacol · 200819 citationsRCR 0.7
- Comparative evaluation of the effects of an alum-containing mouthrinse and a saturated saline rinse on the salivary levels of Streptococcus mutans.J Indian Soc Pedod Prev Dent · 201018 citationsRCR 1.0
- 10 citationsRCR 0.7
- The comparative evaluation of the effects of tongue cleaning on salivary levels of mutans streptococci in children.Int J Dent Hyg · 20125 citationsRCR 0.3
- Comparison of Patient Comfort During the First Stage of Conventional Versus Modified Two-Stage Inferior Alveolar Nerve Blocks in Pediatric Patients.Anesth Prog · 20192 citationsRCR 0.3
- Pharmacokinetics of Omadacycline in Adults with Cystic Fibrosis.Clin Pharmacokinet · 20241 citationsRCR 0.2